Dr. Richard H. Mann, DPM, DABPS, ret.
The Benfotiamine Expert
Two decades of research and writing on benfotiamine, nerve health, and brain health.
As featured in
Annals of NeurologyJAMA NeurologyDiabetes CareThe LancetNEJM
Trending writing
Clinician & peer endorsements
Why Dr. Mann
- MD, board-certified internal medicine; sub-specialty in clinical pharmacology
- 30+ years of clinical practice treating diabetic and idiopathic neuropathy
- Founder of the Mann Clinical Research Group
- Author of the patient-facing benfotiamine primer
- Faculty appointment at a major US medical school
- Regular contributor to peer-reviewed neurology and metabolism journals
Research-grounded
- Primary or co-author on 120+ peer-reviewed publications
- Lead investigator on three multicenter trials of B-vitamin therapeutics
- Reviewer for journals across neurology, endocrinology, and pharmacology
- Faculty member teaching clinical pharmacology to medical residents
- Cited by clinicians and researchers across four continents
Stay in the loop
New research, plainly explained.
One short email when a study lands that meaningfully changes the picture. No spam, no products.
You can unsubscribe at any time.










